PLOS Biology
Cure8 research brief
Why This Matters
The paper describes a specific immune–microbe pathway (HMB-PP → Vδ2+ γδ T-cells → IL-22) that suppresses Candida in healthy human gut tissue but is impaired in Crohn’s disease, which could help explain fungal overgrowth and barrier invasion seen in some patients.
Who Should Pay Attention
Researchers (immune–microbiome, fungal pathobionts), clinicians interested in IBD pathogenesis, and informed patients interested in basic-science mechanisms of Crohn’s disease.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study used human intestinal organ cultures, genomic/proteomic analysis of Candida isolates, and an intestine-on-a-chip model to show a pathway linking bacterial metabolites, Vδ2+ γδ T-cell activation, IL-22 production, and suppression of fungal pathobionts.
In Crohn’s disease samples, Vδ2+ cells were less responsive to HMB-PP and failed to control Candida, which showed traits associated with tissue invasion and toxin production.
The findings are mechanistic and preclinical: they identify an immune–microbe interaction that may contribute to fungal overgrowth and barrier invasion in Crohn’s disease, but they do not report clinical interventions or patient outcomes.
Keep In Mind
This is an abstract/partial-excerpt of a basic-science study using organ cultures and in vitro models; findings are preclinical and do not imply clinical benefit or therapeutic recommendations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationPLOS Biology
PublisherPublic Library of Science (PLoS)
AuthorsLiya Mathew, Sean L. Carlson, Michael Savage +21 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedNov 2, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Barts Charity, award MGU0465; Barts Charity, award G-002461; Wellcome Trust, award 223500/Z/21/Z; Horizon Europe, award FunHoMic 812969; NC3Rs, award NC/S001557/1; Academy of Medical Sciences springboard, award SBF007/100175; Biotechnology and Biological Sciences Research Council, award UKRI717; Wellcome Trust, award 214229/Z/18/Z; Horizon Europe, award HDM-FUN 847507; Medical Research Council, award MR/R008302/1
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation.
The paper identifies Candida albicans–reactive Th17 cells that travel between oral and gut mucosa and become more pathogenic in Crohn’s disease, suggesting a fungal–immune link that could matter for disease mechanisms...
Sutterella Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation byspecies.
Researchers identify a gut microbe (Sutterella species) that may worsen intestinal inflammation by blocking AhR-driven IL-22 and IL-17 responses—pathways that help protect the gut lining.
Adherent-invasive Escherichia coli pduB drives vitamin B12-dependent colitis in mice.
If AIEC contribute to Crohn’s disease for a given person, this study suggests host vitamin B12 levels and bacterial pdu pathway activity might influence bacterial invasion and inflammation — potentially pointing to new...